首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   21843篇
  免费   759篇
  国内免费   79篇
化学   17182篇
晶体学   125篇
力学   334篇
数学   2755篇
物理学   2285篇
  2023年   164篇
  2022年   198篇
  2021年   898篇
  2020年   523篇
  2019年   568篇
  2018年   452篇
  2017年   369篇
  2016年   750篇
  2015年   674篇
  2014年   731篇
  2013年   1341篇
  2012年   1402篇
  2011年   1560篇
  2010年   980篇
  2009年   891篇
  2008年   1315篇
  2007年   1259篇
  2006年   1117篇
  2005年   960篇
  2004年   807篇
  2003年   655篇
  2002年   633篇
  2001年   302篇
  2000年   246篇
  1999年   176篇
  1998年   187篇
  1997年   151篇
  1996年   218篇
  1995年   177篇
  1994年   145篇
  1993年   158篇
  1992年   132篇
  1991年   136篇
  1990年   116篇
  1989年   131篇
  1988年   103篇
  1987年   93篇
  1986年   101篇
  1985年   118篇
  1984年   130篇
  1983年   79篇
  1982年   127篇
  1981年   114篇
  1980年   98篇
  1979年   91篇
  1978年   83篇
  1977年   78篇
  1976年   71篇
  1974年   59篇
  1963年   57篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
994.
995.
996.
Middle East respiratory syndrome coronavirus (MERS-CoV) causes high fever, cough, acute respiratory tract infection and multiorgan dysfunction that may eventually lead to the death of the infected individuals. MERS-CoV is thought to be transmitted to humans through dromedary camels. The occurrence of the virus was first reported in the Middle East and it subsequently spread to several parts of the world. Since 2012, about 1368 infections, including ~487 deaths, have been reported worldwide. Notably, the recent human-to-human ‘superspreading'' of MERS-CoV in hospitals in South Korea has raised a major global health concern. The fatality rate in MERS-CoV infection is four times higher compared with that of the closely related severe acute respiratory syndrome coronavirus infection. Currently, no drug has been clinically approved to control MERS-CoV infection. In this study, we highlight the potential drug targets that can be used to develop anti-MERS-CoV therapeutics.  相似文献   
997.
998.
999.
1000.
Dihydralazine and hydrochlorothiazide were stored at high temperature and humidity, under UV/Vis light and different pH, as individual drugs and the mixture. Then, a sensitive and selective HPLC-UV method was developed for simultaneous determination of dihydralazine and hydrochlorothiazide in presence of their degradation products. Finally, the degradation products were characterized through LC-DAD and LC–MS methods. Dihydralazine was sensitive to high temperature and humidity, UV/Vis light and pH?≥?7. At the same time, it was resistant to acidic conditions. Hydrochlorothiazide was sensitive to high temperature and humidity, UV/Vis light and changes in pH. Its highest level of degradation was observed in 1 M HCl. Degradation of the drugs was higher when they were stressed in the mixture. In the case of dihydralazine, the percentage degradation was 5–15 times higher. What is more, dihydralazine became sensitive to acidic conditions. Hydrochlorothiazide was shown to be more sensitive to UV/Vis light and pH?>?4. Degradation of dihydralazine and hydrochlorothiazide followed first-order kinetics. The quickest degradation of dihydralazine was found to be in 1 M NaOH while of hydrochlorothiazide was in 1 M HCl (individual hydrochlorothiazide) or at pH 7–10 (hydrochlorothiazide in the mixture). A number of new degradation products were detected and some of them were identified by our LC-DAD and LC–MS methods. In the stressed individual samples, (phenylmethyl)hydrazine and 1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide were observed for the first time. Interactions between dihydralazine and hydrochlorothiazide in the mixture were confirmed by additional degradation products, e.g., 2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1,4-trioxide.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号